Pinar Cicalese

Director, CMC Commercial Strategy • Immatics

Dr. Pinar Cicalese is the Director of CMC Commercial Strategy at Immatics for adoptive cell therapies targeting various solid cancers. Pinar has nearly 20 years of experience in early-stage development through launch and growth of biological assets in companies of various sizes. Before joining Immatics, she has been responsible for GlaxoSmithKline Cell and Gene Therapy platform manufacturing and supply strategy. Prior to this she has led a Manufacturing Science and Technology group in GlaxoSmithKline delivering many late-stage and commercial Biopharmaceutical assets. Pinar holds a PhD in Chemical Engineering from Drexel University and was a Fulbright scholar during her PhD studies.

Also Speaking

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings • American Red Cross

Barbara A. Binzak Blumenfeld

Shareholder, FDA & Biotechnology • Buchanan Ingersoll Rooney

Paul Kosnik

Vice President, Clinical Development • Orgenesis

Event Info


Fun Run